INTRODUCTION
============

The first successful liver transplantation was performed by Starzl in the USA in 1967[@B18]. This transplant was considered a non-experimental procedure by the National Institutes of Health of the USA in 1983[@B18]. The first successful liver transplantation in Brazil occurred in São Paulo in 1985. The Clinical Hospital of the Federal University of Parana was the first institution to perform this transplantation in the State of Parana in Curitiba in September of 1991[@B11]. Up to present, a total of 534 liver transplantations was performed in this institution. At the moment, Brazil in the third country of the world in number of liver transplantations performed, after the USA and China[@B5].

Biliary reconstruction is considered the Achilles's heel of the liver transplantation. Biliary complications (BC) are frequent, increase hospital stay, cost, and operative mortality[@B9]. Quality of life is decreased in patients with these complications due to need of percutaneous, endoscopic and surgical procedures[@B23]. Even after the advances in transplant patient care and in surgical technique in t he last decades, biliary complications remain the most common postoperative technical complication.

Several risk factors correlate with biliary complications. The most important are hepatic artery thrombosis, acute cellular rejection, liver cold ischemia time, and donor and receptor old age[@B20]. There are only a few publications that correlate these risk factors with the occurrence of biliary complications in Brazil.

The objective of the present study was to evaluate the incidence, the risk factors and the treatment of biliary complications after liver transplantation.

METHODS
=======

This study was approved by the Scientific Committee of Ethics of our institution (\#CAAE 50988615.0.0000.0096).

Candidates were selected for liver transplantation by a multidisciplinary committee based on clinical and laboratory data. The waiting list order for transplantation was based on the waiting time up to 2006 and afterwards on the MELD score[@B14].

The surgical technique employed for cadaveric and living-donor liver transplantation was described previously[@B6] ^-^ [@B8]. Venovenous bypass was not employed in this series. Biliary reconstruction was performed after vascular anastomosis. Biliary anastomosis was performed with polydioxanone absorbable suture 6-0 or 7-0, either with separated stitches or with two continuous sutures (anterior and posterior). The knots were tied on the outer surface of the anastomosis.

Biliary reconstruction was preferably performed with termino-terminal anastomosis of donor's and receptor's main bile ducts. In the living donor liver transplantation, the right or the left hepatic duct of the donor was anastomosed to the common hepatic duct of the receptor.

In the presence of more than one biliary duct on the donor, ductoplasty was performed in order to create only one anastomosis between these two joined ducts and the common hepatic duct of the receptor. When ductoplasty was not possible, the two or three bile ducts of the donor were anastomosed to a Roux-en-Y jejunum limb (Roux-en-Y hepaticojejunostomy). In patients with primary sclerosing cholangitis, a Roux-en-Y hepaticojejunostomy was employed primarily.

Bile duct drainage was not employed. A closed suction drain with two tubes was used routinely. One tube was placed in the subphrenic space and the other in the liver hilum area. For living donor liver transplantation, both the donor and receptor were subjected to magnetic resonance cholangiography. Operative cholangiography was not performed routinely.

Medical records of the patients who underwent liver transplantation were reviewed retrospectively. Patients who did not have complete information were excluded from the study. The analyzed data included type of transplantation, biliary tract reconstruction, presence of vascular and biliary complications, presence of other postoperative complications and method and result of the treatment of biliary complications. The diagnosis of biliary complications was based on clinical, laboratory and imaging exams. The diagnosis of hepatic artery thrombosis was established by Doppler ultrasonography and confirmed by arteriography or angiotomography.

Statistical analysis
--------------------

The values were expressed in mean of simple frequency. The data was evaluated by the Mann-Whitney test, Kruskal-Wallis test and Fisher Test. Differences were considered significant if p≤0.05.

RESULTS
=======

Of a total of 326 liver transplantations performed in 310 patients in the period from June 1, 2001 to August 4, 2015, 182 medical charts were evaluated. Of this group, 49 patients (26.92%) had biliary complications after transplantation.

The demographic characteristic of the receptors are shown in [Table 1](#t1){ref-type="table"}. The age of the receptors varied from six months to 70 years, with an average of 47 years. A total of 127 patients (69.78%) were males and 55 females (30.22%). Cadaveric liver transplantation was done in 153 patients (84.07%) and living donor liver transplantation in 29 (15.93%). All receptors had the same ABO blood group of the donors.

TABLE 1Factors analyzed to evaluate the risk of biliary complicationsFactors evaluatedPresence of biliary complications (n = 49)Absence of biliary complications (n= 133)pTotalMean Age46.6747.520.3366Male36 (73.47%)91 (68.42%)0.5872127Female13 (26.53%)42 (31.58%)55Type of transplantationCadaveric37 (24.18%)116 (75.82%)0.06840Living Donor12 (41.38%)17 (58.62%)0Biliary reconstructionColedocho-coledochostomy44 (26.99%)119 (73.01%)0.7816163Hepaticojejunostomy5 (29.41%)12 (70.59%)17Hepatic artery thrombosis10 (20.4%)7 (5.26%)0.0038317Acute cellular rejection17 (34.7%)30 (22.5%)0.12747Hepatocellular Carcinoma14 (28.6%)31 (23.3%)0.561945CMV Infection5 (10.2%)9 (6.77%)0.533914

The indications of liver transplantation are shown in [Figure 1](#f1){ref-type="fig"}. The most common indications were advanced chronic liver disease caused by virus C hepatitis and alcoholic cirrhosis, followed by autoimmune disease and advanced chronic liver disease virus B hepatitis. Presence of hepatocellular carcinoma was analyzed separately.

Of 153 cadaveric liver transplantations, 37 (24.1%) had biliary complications: seven fistulas, 26 stenosis, and four stenosis with previous fistula. Of 29 living donor liver transplantations, 12 (41.4%) had biliary complications: seven fistulas, two stenoses, and three stenoses with previous fistula.

The most common biliary complication was stenosis that occurred in 35 patients (19.23%). In seven, the stenosis was preceded by fistula. The diagnosis of biliary fistula was established in the 1^st^ postoperative month all but one patient that was recognized only in the 5^th^ month. Biliary fistula was the most common biliary complication of the living donor liver transplantation. Twenty-five percent of the patients with fistula in this type of transplant had biliary stenosis later. Fistula followed by stenosis was diagnosed in 10.8% of the patients of the group of cadaveric transplantation group.

FIGURE 1Indications of liver transplantation in absolute numbers

Four patients with fistula had conservative treatment with good recovery ([Table 2](#t2){ref-type="table"}). Three were subjected to surgical treatment in the 1^st^ postoperative month: a) two with hepatic artery thrombosis underwent retransplantation and died in the immediate postoperative period of septic shock; b) one had good recovery following Roux-en-Y hepaticojejunostomy.

TABLE 2Methods employed for treatment of biliary complicationsTreatmentn%Endoscopic treatment1224.5Stenosis510.2Fistula510.2Fistula + stenosis24.08Percutaneous treatment612.24Stenosis48.16Fistula12.04Fistula + stenosis12.04Endoscopic + percutaneous510.2Stenosis510.2Surgical treatment510.2Stenosis24.08Fistula36.12Endoscopic percutaneous + surgical1632.65Stenosis12 (3 THCP. 2 ERCP. 7 both)24.5Stenosis + fistula4 (1 THCP. 1 ERCP. 2 both)8.16Spontaneous resolution48.16Biliary drainage unknown12.04Total49100

Most patients with fistula were subjected to endoscopic and or percutaneous procedures for diagnosis and treatment (58.8%). These procedures were performed in average in 2.35 times (1 to 5 procedures) in each patient with fistula. The most common procedure used was the endoscopic (in 8 of 10 patients). Fistula resolution occurred in six patients. Complications following endoscopic treatment of the fistula were recorded in three patients (30%): acute pancreatitis, hemorrhage, and acute cholangitis.

Compared to the fistula, biliary stenosis was diagnosed later, in average in the 11^th^ postoperative month. Presence of laboratory exams of cholestasis and magnetic resonance cholangiography findings of dilations and strictures were used to establish the diagnosis of biliary stenosis. Stenosis treatment was performed with endoscopic (n=7) or percutaneous (n=7) biliary dilation. Both endoscopic and percutaneous dilations were used in 12 patients. The average number of dilation was 4.3 (1 to 16 dilations). Resolution of the stenosis was observed in 11 patients: two with endoscopic access, four with percutaneous access, and five with both accesses. A total of 11 patients with no resolution with dilation needed surgical treatment.

Five of 26 (19.23%) patients that needed treatment of the biliary stenosis had complications: infection in two, pancreatitis in two, and migration of the catheter in one. [Table 2](#t2){ref-type="table"} shows the methods employed for treatment of biliary complications.

Hepatic artery thrombosis occurred in 17 (9.34%) patients. All them were recognized in the 1^st^ postoperative week. Ten of these patients (58.82%) had biliary complications: six stenosis, three fistulas, and one stenosis preceded by fistula. All biliary stenoses were initially treated with dilation, with an average of 7.8 dilations per patient. Two had endoscopic dilation and five required both percutaneous and endoscopic dilations. The rate of resolution with dilation was 42.86%. Two patients needed surgical treatment: one Roux-en-Y hepaticojejunostomy and one retransplantation.

Biliary fistula occurred in four patients with hepatic artery thrombosis. One was treated with Roux-en-Y hepaticojejunostomy and two with retransplantation. The presence of hepatic artery thrombosis increased in the incidence of biliary complications in 2.47 times (p=0.0038).

The average MELD score for all patients was 17, similar to the average of patients with biliary complications (17.4). However, the incidence of biliary complications was higher in patients with MELD higher than 25 (2 of 7 patients; 28.5%).

There was no difference of incidence of biliary complications in patients with acute cellular rejection (17 of 47 patients; p=0.127), hepatocellular carcinoma (11 of 45 patients; p=0.5619), hepatitis virus recurrence (6 of 26 patients; p=0.812, [Table 1](#t1){ref-type="table"}). There was no relationship between the incidence of biliary complications and age above 60 years (p=1.0) or gender (p=0.587, [Table 1](#t1){ref-type="table"}).

Of the 17 patients who underwent Roux-en-Y hepaticojejunostomy, 11 had

good recovery, three died, two had biliary fistula and one underwent retransplantation ([Figure 2](#f2){ref-type="fig"}). Of the eight patients who were subjected to retransplantation, two had good recovery, one had biliary stenosis e five died.

FIGURE 2A) Frequency of complications after endoscopic, percutaneous or combinations of these procedures (n=11); B) complications of biliary complications treated surgically with either retransplantation or reanastomosis (n=16)Note: Patients who presented more than one complication were allocated in more than one category.

DISCUSSION
==========

Biliary complications following liver transplantation are common and increase postoperative morbidity and mortality[@B1] ^,^ [@B20]. The high incidence is related to the biliary tract vascularization that is exclusively supplied by vessels originated from the hepatic artery[@B19]. Collateral arterial supply to the biliary tract is suctioned during liver removal for transplantation. Thus, hepatic artery thrombosis causes ischemia and irreversible damage to the intra and extra-hepatic biliary tree[@B13].

Other factors associated to biliary complications included acute rejection, iImmunosuppression, ABO incompatibility, cytomegalovirus infection, and technical factors[@B14]. Acute rejection causes reduction of blood flow and increase of liver volume that predispose to arterial thrombosis. Immunosuppression changes the inflammatory response necessary to healing and formation of normal fibrotic tissue. Cytomegalovirus infection causes vasculitis that reduces hepatic vascularization[@B8].

Recently, Nemes et al reported a correlation between biliary complications and elevated MELD score(\>25), elevated level of pre-transplant plasmatic sodium, presence of hepatocellular carcinoma, advanced age of the donor (\>60 years), prolonged time of anehepatic phase, prolonged time of cold ischemia (\>12 h) and duration of stay in the intensive care unit[@B20].Some ofthese factors were not evaluated in our study to the lack of complete data in the medical records of several patients.

Of the several potential risk factors evaluated, hepatic artery thrombosis was the only one that was associated with increase in the incidence of biliary complications. The lack of increase of biliary complications in patients with acute rejection, presence of hepatocellular carcinoma, viral hepatitis recurrence, and patient's age above 60 years observed in this study is possibly due the small number of patients evaluated.

The incidence of hepatic artery thrombosis in this study was 9.3%. Biliary complications occurred in 58.7% of these patients and almost two thirds needed retransplantation. The rate of hepatic artery thrombosis reported in the literature varies from 2.5 to 6.8%[@B13].

Our biliary complication rate of 26.9% is similar to other studies[@B1] ^,^ [@B9] ^,^ [@B13] ^,^ [@B20]. Living donor liver transplantation was almost two times the rate of cadaveric transplantation. In addition to the small size of the biliary duct in the living donor transplantation, some patients have two or more small ducts that need anastomosis.

The explanation for the wide variation of the rate of biliary complications among the transplantation centers was evaluated by some authors. After statistical correction of individual risk factors, Axelrod et al. reported a variation of 75% between the observed and the expected incidence of biliary complications in American hospitals[@B2]. The possible reasons of the variation include smaller number of transplantations and smaller rate of split liver. It is also important to mention that our public university hospital lacks both specialized personnel and modern equipments.

The most common biliary complication was stenosis, followed by fistula. Healing of fistula may cause biliary stenosis[@B22]. Biliary fistula occurs earlier than stenosis[@B15]. In this study, all fistulas were diagnosed in the 1^st^ month post- transplantation, while stenoses were recognized on average on the 11^th^ month.

Biliary stenosis was treated with duct dilation with a balloon, both by endoscopic or percutaneous access. Surgical treatment was indicated in case of endoscopic and or percutaneous treatment failure. Although the primary treatment of fistulas was also endoscopic and or percutaneous interventions, a higher rate of patients with fistula required primary surgical treatment. Retransplantation was needed in patients with hepatic artery thrombosis or after failure of multiple treatments. Our resolution rate of biliary complications by percutaneous and or endoscopic access was similar to other centers[@B21].

Our retransplantation rate for treatment of biliary complications was 62.5%, higher than most reports[@B3] ^,^ [@B4] ^,^ [@B16] ^,^ [@B17]. This is possibly due to limitations of our public hospital, as mentioned earlier.

CONCLUSION
==========

Biliary complications are frequent after liver transplantation. These complications require several other endoscopic, percutaneous and surgical procedures that increase the morbidity and mortality and reduce the quality of life of these patients. Hepatic artery thrombosis increases the rate of biliary complications.
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